Clinical Trials Sponsored by RepoCeuticals ApS

Total 1155 results

AHS Cancer Control Alberta

Recruiting

Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients

Glioblastoma Multiforme

Canada
AHS Cancer Control Alberta

Recruiting

Pre- Versus Post-operative SRS for Resectable Brain Metastases

Brain Metastases

Canada
AHS Cancer Control Alberta

Recruiting

HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis (ATG2017)

Relapse | Graft-versus-host-disease

Canada
AHS Cancer Control Alberta

Recruiting

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

Carcinoma, Neuroendocrine

Canada
AHS Cancer Control Alberta

Terminated

Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate (PREMIUM)

Prostatic Neoplasm

Canada
AHS Cancer Control Alberta

Completed

Multi-Parametric Brain Cancer MRI

Brain Tumors

Canada
SOTIO a.s.

Completed

Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer

Stage IV Non-small Cell Lung Cancer

Czechia, Slovakia
SOTIO a.s.

Completed

DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer

Ovarian Cancer Recurrent

Czechia
AHS Cancer Control Alberta

Completed

A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland (PET PRO)

Prostatic Neoplasms

Canada
Columbia University
ALS Association

Terminated

Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

United States
AHS Cancer Control Alberta

Terminated

Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment

Colon Cancer

Canada
AHS Cancer Control Alberta

Withdrawn

Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib

Fatigue | Renal Cell Cancer

Canada
AHS Cancer Control Alberta

Terminated

Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy (CIPN)

Peripheral Neuropathy in Breast Cancer Patient

Canada
AHS Cancer Control Alberta

Withdrawn

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

Hypoxic Tumours
Emory University
ALS Association

Completed

Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) (NIPALS2013)

Amyotrophic Lateral Sclerosis (ALS)

United States
AHS Cancer Control Alberta

Completed

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours

Lung Neoplasms | Lung Cancer

Canada
AHS Cancer Control Alberta

Unknown

A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely

Neoplasm Metastasis | Colonic Neoplasms
AHS Cancer Control Alberta

Unknown

Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients (CHIRP)

High-risk Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

Breast Cancer

Canada
AHS Cancer Control Alberta

Unknown

Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology

Glioma

Canada
AHS Cancer Control Alberta

Completed

Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers

Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors

Colonic Neoplasms

Canada
AHS Cancer Control Alberta

Completed

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

Glioma

Canada
AHS Cancer Control Alberta

Terminated

Blood Test to Measure DNA Damage in Blood

Prostate Cancer

Canada
AHS Cancer Control Alberta

Terminated

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

Gastric Cancer | Esophageal Cancer | Tumors

Canada
AHS Cancer Control Alberta

Unknown

Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone

Bone Scan

Canada
AHS Cancer Control Alberta

Unknown

Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components

Glioma

Canada
AHS Cancer Control Alberta

Completed

Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients

Seminoma | Testicular Cancer | Non-seminomatous

Canada
AHS Cancer Control Alberta

Terminated

Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

Metastatic Breast Cancer

Canada
SNIPR Biome Aps.
Wellcome Trust; Biomedical Advanced Research and Development Authority

Completed

A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects

Bloodstream Infection | E.Coli Infections

United States
AHS Cancer Control Alberta

Recruiting

A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer

Prostate Cancer | Oncology

Canada
AHS Cancer Control Alberta

Recruiting

PSMA-PET/CT Registry

Prostate Cancer

Canada
AHS Cancer Control Alberta

Not yet recruiting

Loratadine for the Prevention of G-CSF-related Bone Pain

Stem Cell Transplant Complications

Canada
AHS Cancer Control Alberta

Not yet recruiting

Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)

Gynecologic Cancer | Iron-deficiency | Anemia

Canada
AHS Cancer Control Alberta

Not yet recruiting

Nutritional Supplementation in Head and Neck Cancers

Nutritional Deficiency | Malnourishment | Undernutrition

Canada
AHS Cancer Control Alberta

Recruiting

A Study Involving Neoadjuvant Chemoradiotherapy With Hypofractionated Radiotherapy in Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma

Esophageal Cancer

Canada
Target ALS Foundation, Inc.

Recruiting

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures (TALSLB)

Movement Disorders | Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Degenerative Disorder

United States
ASP Health
Mayo Clinic

Not yet recruiting

Clinical Evaluation of ASP Health's Automated ROSE System for Bronchoscopic Applications

Lung Diseases | Lung Cancer
AHS Cancer Control Alberta

Recruiting

Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer (INSPIRE)

Anal Canal Cancer

Canada
AHS Cancer Control Alberta

Recruiting

Prognostic Indicators for Radiation-induced Breast Fibrosis

Breast Cancer

Canada
AHS Cancer Control Alberta

Recruiting

Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer (DARTS)

Small Cell Lung Cancer

Canada
AHS Cancer Control Alberta

Recruiting

Immune-Mediated Pathophysiology And Clinical Triage Program (IMPACT 2)

Arthritis | Arthralgia

Canada
AHS Cancer Control Alberta

Recruiting

A Nutritional Supplement to Support People With Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Canada
AHS Cancer Control Alberta

Recruiting

A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use

Neuroendocrine Tumors

Canada
AHS Cancer Control Alberta

Recruiting

Chemoradiotherapy for Advanced Esophageal Cancer (PaRCUS)

Esophageal Cancer

Canada
AHS Cancer Control Alberta

Recruiting

A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients

Breast Neoplasms

Canada
AHS Cancer Control Alberta

Active, not recruiting

Exercise and Compression for Lymphedema (DREAM)

Breast Cancer Related Lymphedema

Canada
SOTIO a.s.

Completed

Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer (VIABLE)

Metastatic Castration-resistant Prostate Cancer

United States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
SOTIO a.s.

Terminated

A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer

Castration-resistant Prostate Cancer

Czechia
AHS Cancer Control Alberta

Terminated

A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Lymphoma | Cancer | Solid Tumor | Brain Cancer

Canada

3

Subscribe